Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluMist vs TIV in Children 6-36 Months
NCT00111579Phase 2Completed
- Sponsor
- MedImmune
- Start
- May 2005
- Primary completion
- Jan 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by MedImmune. Primary endpoints: Strain-specific HAI seroconversion rates (>= 4-fold increase) and Proportion of participants achieving >= 4-fold increase in strain-specific HAI titer. Started May 2005; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00111579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111579.